# Meridian Medical wins $129M contract for nerve agent antidote DuoDote

Meridian Medical Technologies, a unit of Kindeva, secured a $129 million contract to supply the U.S. with the nerve agent antidote autoinjector DuoDote. The autoinjectors will be produced in St. Louis.

- Type: Contract
- Announced: 2025-01-22
- Where: St. Louis, United States
- Value: $129.0M
- Status: completed
- Products: DuoDote autoinjector
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Meridian Medical Technologies](https://endata.com/companies/61884.md)
- [Kindeva](https://endata.com/companies/82489.md) (partner)

## Sources

- [fiercepharma.com](https://www.fiercepharma.com/manufacturing/kindeva-unit-meridian-medical-snares-129m-supply-us-nerve-agent-antidote), 2025-01-22: "This contract underscores the ongoing importance of maintaining readiness against potential threats."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.